UPDATE - UBS downgrades BioMarin (Nasdaq: BMRN) from Buy to Neutral. PT upped $2 to $28.

UBS analyst says, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE